acetaminophen 325 MG / doxylamine succinate 6.25 MG / phenylephrine hydrochloride 5 MG Oral Capsule

RxCUI: 1052647
RxNorm name: acetaminophen 325 MG / doxylamine succinate 6.25 MG / phenylephrine hydrochloride 5 MG Oral Capsule
Display name: Acetaminophen/Doxylamine/Phenylephrine (Oral Pill)
Full name: acetaminophen 325 MG / doxylamine succinate 6.25 MG / phenylephrine hydrochloride 5 MG Oral Capsule
Term type: SCD
Status: Active
Strength: 325-6.25-5 mg
Dose form: Cap
Route: Oral Pill
Updated: 2026-06-13 07:09:28

RxNorm Status History#

Status: Active
Source: RXNORM
Current: YES
Release start: 022011
Active start: 022011
Multiple ingredient: YES
Branded: NO

Ingredients And Strength#

Ingredient, Strength, Base table
Ingredient	Strength	Base	Basis of strength
acetaminophen	325 MG / 1 EACH	acetaminophen	acetaminophen
doxylamine succinate	6.25 MG / 1 EACH	doxylamine	doxylamine succinate
phenylephrine hydrochloride	5 MG / 1 EACH	phenylephrine	phenylephrine hydrochloride

Dose Form Concepts#

Dose form, RxCUI table
Dose form	RxCUI
Oral Capsule	316965

Derived Ingredient Concepts#

Ingredient, RxCUI table
Ingredient	RxCUI
acetaminophen	161
doxylamine	3642
phenylephrine	8163

Source Vocabulary Codes#

Code type, Value, Category table
Code type	Value	Category
PRESCRIBABLE	Y	ATTRIBUTES
RXNAV_STR	acetaminophen 325 MG / doxylamine succinate 6.25 MG / phenylephrine hydrochloride 5 MG Oral Capsule	NAMES
RxNorm Name	acetaminophen 325 MG / doxylamine succinate 6.25 MG / phenylephrine hydrochloride 5 MG Oral Capsule	NAMES
RxNorm Synonym	APAP 325 MG / doxylamine succinate 6.25 MG / Phenylephrine Hydrochloride 5 MG Oral Capsule	NAMES
TTY	SCD	ATTRIBUTES
SPL_SET_ID	0f3b1404-9252-470a-aa8c-b360c85731f3	CODES
SPL_SET_ID	413d82d3-a896-4f15-9fca-c1b7b9a1ee63	CODES
SPL_SET_ID	d538445e-a47d-4983-844f-38aa303d11fd	CODES
RxCUI	1052647	CODES
MMSL_CODE	BD28700	CODES
MMSL_CODE	CD28700	CODES

FDA NDC Products And Packages#

Package NDC, Product NDC, Name table
Package NDC	Product NDC	Name	Labeler	Application
53345-013-01	53345-013	NightTime Sinus Relief Acetaminophen, Doxylamine succinate, Phenylephrine hydrochloride	Humanwell PuraCap Pharmaceutical (Wuhan), Ltd.	M012
53345-031-01	53345-031	NightTime Sinus Acetaminophen, Doxylamine succinate, Phenylephrine hydrochloride	Humanwell PuraCap Pharmaceutical (Wuhan) Co., Ltd.	M012

Drugs@FDA Applications#

Application, NDC, Name table
Application	NDC	Name	Marketing category	Labeler
M012	53345-013	NightTime Sinus Relief Acetaminophen, Doxylamine succinate, Phenylephrine hydrochloride	OTC MONOGRAPH DRUG	Humanwell PuraCap Pharmaceutical (Wuhan), Ltd.

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 39 matching rows.

NDC11, Source, Active table
NDC11	Source	Active
23900002328	rxnav_ndcs	yes
51013011314	rxnav_ndcs	yes
53345001301	rxnav_ndcs	yes
53345003101	rxnav_ndcs	yes
68016020116	rxnav_ndcs	yes
68016063116	rxnav_ndcs	yes
00280119820	rxnav_historical
23900001448	rxnav_historical
23900001983	rxnav_historical
36800010116	rxnav_historical
36800010124	rxnav_historical
36800040862	rxnav_historical
37000040824	rxnav_historical
37000050824	rxnav_historical
37000080620	rxnav_historical_indirect
37000080624	rxnav_historical
41250010124	rxnav_historical
41250024762	rxnav_historical
41520010116	rxnav_historical
42507030562	rxnav_historical
46122000660	rxnav_historical
49035024760	rxnav_historical
50804010124	rxnav_historical
51013015604	rxnav_historical
51013016004	rxnav_historical
51013018614	rxnav_historical
55312010112	rxnav_historical
55312010116	rxnav_historical
55315010216	rxnav_historical
59726010108	rxnav_historical
59779010116	rxnav_historical
59995000700	rxnav_historical
63868038812	rxnav_historical
63868038820	rxnav_historical
68016010112	rxnav_historical
68016073316	rxnav_historical
68210148005	rxnav_historical
68210148006	rxnav_historical
76270011408	rxnav_historical

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
NightTime Sinus Relief	ACETAMINOPHEN, DOXYLAMINE SUCCINATE, PHENYLEPHRINE HYDROCHLORIDE	Humanwell PuraCap Pharmaceutical (Wuhan), Ltd.	413d82d3-a896-4f15-9fca-c1b7b9a1ee63	2024-11-25	Warnings	Exact identifier ndc (package): 53345-013-01 ndc (product): 53345-013 ndc11 (package): 53345001301 rxcui: 1052647
NightTime Sinus	ACETAMINOPHEN, DOXYLAMINE SUCCINATE, PHENYLEPHRINE HYDROCHLORIDE	Humanwell PuraCap Pharmaceutical (Wuhan) Co., Ltd.	0f3b1404-9252-470a-aa8c-b360c85731f3	2024-11-25	Warnings	Exact identifier ndc (package): 53345-031-01 ndc (product): 53345-031 ndc11 (package): 53345003101 rxcui: 1052647

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
0f3b1404-9252-470a-aa8c-b360c85731f3	acetaminophen 325 MG / doxylamine succinate 6.25 MG / phenylephrine HCl 5 MG Oral Capsule	PSN	3	NightTime Sinus Capsule, liquid filled	20241125
0f3b1404-9252-470a-aa8c-b360c85731f3	acetaminophen 325 MG / doxylamine succinate 6.25 MG / phenylephrine hydrochloride 5 MG Oral Capsule	SCD	3	NightTime Sinus Capsule, liquid filled	20241125
0f3b1404-9252-470a-aa8c-b360c85731f3	APAP 325 MG / doxylamine succinate 6.25 MG / Phenylephrine Hydrochloride 5 MG Oral Capsule	SY	3	NightTime Sinus Capsule, liquid filled	20241125
413d82d3-a896-4f15-9fca-c1b7b9a1ee63	APAP 325 MG / doxylamine succinate 6.25 MG / Phenylephrine Hydrochloride 5 MG Oral Capsule	SY	3	NightTime Sinus Relief capsule, liquid filled	20241125
413d82d3-a896-4f15-9fca-c1b7b9a1ee63	acetaminophen 325 MG / doxylamine succinate 6.25 MG / phenylephrine HCl 5 MG Oral Capsule	PSN	3	NightTime Sinus Relief capsule, liquid filled	20241125
413d82d3-a896-4f15-9fca-c1b7b9a1ee63	acetaminophen 325 MG / doxylamine succinate 6.25 MG / phenylephrine hydrochloride 5 MG Oral Capsule	SCD	3	NightTime Sinus Relief capsule, liquid filled	20241125
649f429a-ba62-4ef0-9c7f-940bbf18dbf0	acetaminophen 325 MG / doxylamine succinate 6.25 MG / phenylephrine hydrochloride 5 MG Oral Capsule	SCD	2	Night Time Sinus Relief	20200103
649f429a-ba62-4ef0-9c7f-940bbf18dbf0	APAP 325 MG / doxylamine succinate 6.25 MG / Phenylephrine Hydrochloride 5 MG Oral Capsule	SY	2	Night Time Sinus Relief	20200103
649f429a-ba62-4ef0-9c7f-940bbf18dbf0	acetaminophen 325 MG / doxylamine succinate 6.25 MG / phenylephrine HCl 5 MG Oral Capsule	PSN	2	Night Time Sinus Relief	20200103
d538445e-a47d-4983-844f-38aa303d11fd	APAP 325 MG / doxylamine succinate 6.25 MG / Phenylephrine Hydrochloride 5 MG Oral Capsule	SY	2	Daytime Sinus Relief and Nighttime Sinus Relief	20191230
d538445e-a47d-4983-844f-38aa303d11fd	acetaminophen 325 MG / doxylamine succinate 6.25 MG / phenylephrine HCl 5 MG Oral Capsule	PSN	2	Daytime Sinus Relief and Nighttime Sinus Relief	20191230
d538445e-a47d-4983-844f-38aa303d11fd	acetaminophen 325 MG / doxylamine succinate 6.25 MG / phenylephrine hydrochloride 5 MG Oral Capsule	SCD	2	Daytime Sinus Relief and Nighttime Sinus Relief	20191230
4f1ceec0-1273-4cfd-8263-f4247b5e7ee6	acetaminophen 325 MG / doxylamine succinate 6.25 MG / phenylephrine HCl 5 MG Oral Capsule	PSN	2	Nighttime Sinus & Congestion Relief	20191220
4f1ceec0-1273-4cfd-8263-f4247b5e7ee6	APAP 325 MG / doxylamine succinate 6.25 MG / Phenylephrine Hydrochloride 5 MG Oral Capsule	SY	2	Nighttime Sinus & Congestion Relief	20191220
4f1ceec0-1273-4cfd-8263-f4247b5e7ee6	acetaminophen 325 MG / doxylamine succinate 6.25 MG / phenylephrine hydrochloride 5 MG Oral Capsule	SCD	2	Nighttime Sinus & Congestion Relief	20191220
cd1ec9c1-54da-4b73-8d2c-6b727234142c	APAP 325 MG / doxylamine succinate 6.25 MG / Phenylephrine Hydrochloride 5 MG Oral Capsule	SY	2	NiteTime Sinus Relief	20191220
cd1ec9c1-54da-4b73-8d2c-6b727234142c	acetaminophen 325 MG / doxylamine succinate 6.25 MG / phenylephrine HCl 5 MG Oral Capsule	PSN	2	NiteTime Sinus Relief	20191220
cd1ec9c1-54da-4b73-8d2c-6b727234142c	acetaminophen 325 MG / doxylamine succinate 6.25 MG / phenylephrine hydrochloride 5 MG Oral Capsule	SCD	2	NiteTime Sinus Relief	20191220
e3be9ee0-b9bb-4a09-a40a-dbe2f08325ad	APAP 325 MG / doxylamine succinate 6.25 MG / Phenylephrine Hydrochloride 5 MG Oral Capsule	SY	2	N-Time Sinus Soft Gelatin Capsules	20100726
e3be9ee0-b9bb-4a09-a40a-dbe2f08325ad	acetaminophen 325 MG / doxylamine succinate 6.25 MG / phenylephrine HCl 5 MG Oral Capsule	PSN	2	N-Time Sinus Soft Gelatin Capsules	20100726
e3be9ee0-b9bb-4a09-a40a-dbe2f08325ad	acetaminophen 325 MG / doxylamine succinate 6.25 MG / phenylephrine hydrochloride 5 MG Oral Capsule	SCD	2	N-Time Sinus Soft Gelatin Capsules	20100726
842706f9-eedf-1783-49ed-e6b7ae7d650e	acetaminophen 325 MG / doxylamine succinate 6.25 MG / phenylephrine HCl 5 MG Oral Capsule	PSN	1	Drug Facts	20151012
842706f9-eedf-1783-49ed-e6b7ae7d650e	acetaminophen 325 MG / doxylamine succinate 6.25 MG / phenylephrine hydrochloride 5 MG Oral Capsule	SCD	1	Drug Facts	20151012
842706f9-eedf-1783-49ed-e6b7ae7d650e	APAP 325 MG / doxylamine succinate 6.25 MG / Phenylephrine Hydrochloride 5 MG Oral Capsule	SY	1	Drug Facts	20151012

DailyMed Labels#

Set ID, Title, Manufacturer table
Set ID	Title	Manufacturer	Effective
0f3b1404-9252-470a-aa8c-b360c85731f3	NightTime Sinus Capsule, liquid filled	Humanwell PuraCap Pharmaceutical (Wuhan) Co., Ltd.	20241125
413d82d3-a896-4f15-9fca-c1b7b9a1ee63	NightTime Sinus Relief capsule, liquid filled	Humanwell PuraCap Pharmaceutical (Wuhan), Ltd.	20241125
5fda0fc7-956f-4861-8491-259c1abcadd2	Drug Facts	MEIJER, INC.	20230112
208409b1-03cb-4da5-9494-48d0c15bb8e7	Drug Facts	Freds Inc	20211019
3a36815b-7974-6111-e054-00144ff88e88	Vicks ® Sinex™ Nighttime Congestion, Pressure & Pain	The Procter & Gamble Manufacturing Company	20210709
649f429a-ba62-4ef0-9c7f-940bbf18dbf0	Night Time Sinus Relief	PuraCap Pharmaceutical LLC \| Humanwell PuraCap Pharmaceutical (Wuhan) Co., Ltd	20200103
5c421f71-38f0-4215-8d73-f759888b9b6b	DRUG FACTS	Good Sense (Geiss, Destin & Dunn, Inc.)	20191220
4f1ceec0-1273-4cfd-8263-f4247b5e7ee6	Nighttime Sinus & Congestion Relief	PuraCap Pharmaceutical LLC \| Humanwell PuraCap Pharmaceutical (Wuhan) Co., Ltd	20191220
cd1ec9c1-54da-4b73-8d2c-6b727234142c	NiteTime Sinus Relief	PuraCap Pharmaceutical LLC \| Humanwell PuraCap Pharmaceutical (Wuhan) Co., Ltd	20191220
dc65aeb9-b109-4432-8bde-11762e795fda	Drug Facts	TOP CARE (Topco Associates LLC) \| P & L Development, LLC	20190807
7bf0a954-62ae-4d85-af04-10e6c9b521f2	DRUG FACTS	Care One (American Sales Company)	20190715
39601d9e-692d-46fc-9edb-14c908c9de7d	DRUG FACTS	Western Family Foods, Inc.	20181228
8154cf5e-4c43-4814-8fb6-29806d5b1006	DRUG FACTS	P & L Development, LLC	20181226
ff840853-a139-44fb-941a-e9c588f51b15	DRUG FACTS	Chain Drug Consortium, LLC	20151119
842706f9-eedf-1783-49ed-e6b7ae7d650e	Drug Facts	Chain Drug Consortium, LLC \| Accucaps Industries Limited \| Accucaps Industries Limited Strathroy \| Legacy Pharmaceutical Packaging	20151012
03d4a566-dc15-4e5f-9532-c3b21db1368e		National Council for Prescription Drug Programs	20130213
da66683c-5a88-4de5-bd03-78c052cce85a		National Council for Prescription Drug Programs	20120724
e3be9ee0-b9bb-4a09-a40a-dbe2f08325ad	N-Time Sinus Soft Gelatin Capsules	SPIRIT PHARMACEUTICALS,LLC	20100726

Drug Classes#

Source, Class ID, Class table
Source	Class ID	Class	Type	Relationship	Drug concept
ATC	C01CA	Adrenergic and dopaminergic agents	ATC1-4		phenylephrine
ATC	R06AA	Aminoalkyl ethers	ATC1-4		doxylamine
ATC	N02BE	Anilides	ATC1-4		acetaminophen
ATC	C05AX	Other agents for treatment of hemorrhoids and anal fissures for topical use	ATC1-4		phenylephrine
ATC	R01BA	Sympathomimetics	ATC1-4		phenylephrine
ATC	S01FB	Sympathomimetics excl. antiglaucoma preparations	ATC1-4		phenylephrine
ATC	S01GA	Sympathomimetics used as decongestants	ATC1-4		phenylephrine
ATC	R01AB	Sympathomimetics, combinations excl. corticosteroids	ATC1-4		phenylephrine
ATC	R01AA	Sympathomimetics, plain	ATC1-4		phenylephrine
FDASPL	N0000186105	alpha-1 Adrenergic Agonist	EPC	has_epc	phenylephrine
FDASPL	N0000175750	Antihistamine	EPC	has_epc	doxylamine
FDASPL	N0000000207	Histamine Receptor Antagonists	MOA	has_moa	doxylamine
MEDRT	D000082	Acetaminophen	CHEM	has_ingredient	acetaminophen
MEDRT	D004319	Doxylamine	CHEM	has_ingredient	doxylamine succinate
MEDRT	D004319	Doxylamine	CHEM	has_ingredient	doxylamine
MEDRT	D010656	Phenylephrine	CHEM	has_ingredient	phenylephrine hydrochloride
MEDRT	D010656	Phenylephrine	CHEM	has_ingredient	phenylephrine
MEDRT	D013447	Sulfites	CHEM	ci_chemclass	phenylephrine
MEDRT	D013447	Sulfites	CHEM	ci_chemclass	phenylephrine hydrochloride
MEDRT	D004342	Drug Hypersensitivity	DISEASE	ci_with	phenylephrine hydrochloride
MEDRT	D004342	Drug Hypersensitivity	DISEASE	ci_with	acetaminophen
MEDRT	D004342	Drug Hypersensitivity	DISEASE	ci_with	doxylamine succinate
MEDRT	D004342	Drug Hypersensitivity	DISEASE	ci_with	phenylephrine
MEDRT	D004342	Drug Hypersensitivity	DISEASE	ci_with	doxylamine
MEDRT	D005334	Fever	DISEASE	may_prevent	acetaminophen
MEDRT	D005334	Fever	DISEASE	may_treat	acetaminophen
MEDRT	D005401	Fissure in Ano	DISEASE	may_treat	phenylephrine hydrochloride
MEDRT	D005401	Fissure in Ano	DISEASE	may_treat	phenylephrine
MEDRT	D005902	Glaucoma, Open-Angle	DISEASE	may_treat	phenylephrine hydrochloride
MEDRT	D005902	Glaucoma, Open-Angle	DISEASE	may_treat	phenylephrine
MEDRT	D005955	Glucosephosphate Dehydrogenase Deficiency	DISEASE	ci_with	acetaminophen
MEDRT	D006261	Headache	DISEASE	may_treat	doxylamine
MEDRT	D006261	Headache	DISEASE	may_treat	doxylamine succinate
MEDRT	D006484	Hemorrhoids	DISEASE	may_treat	phenylephrine hydrochloride
MEDRT	D006484	Hemorrhoids	DISEASE	may_treat	phenylephrine
MEDRT	D006973	Hypertension	DISEASE	ci_with	phenylephrine hydrochloride
MEDRT	D006973	Hypertension	DISEASE	ci_with	phenylephrine
MEDRT	D007022	Hypotension	DISEASE	may_treat	phenylephrine
MEDRT	D007022	Hypotension	DISEASE	may_treat	phenylephrine hydrochloride
MEDRT	D008107	Liver Diseases	DISEASE	ci_with	acetaminophen
MEDRT	D015878	Mydriasis	DISEASE	induces	phenylephrine hydrochloride
MEDRT	D015878	Mydriasis	DISEASE	induces	phenylephrine
MEDRT	D010146	Pain	DISEASE	may_prevent	acetaminophen
MEDRT	D010146	Pain	DISEASE	may_treat	acetaminophen
MEDRT	D011538	Pruritus Ani	DISEASE	may_treat	phenylephrine
MEDRT	D011538	Pruritus Ani	DISEASE	may_treat	phenylephrine hydrochloride
MEDRT	D012221	Rhinitis, Allergic, Perennial	DISEASE	may_treat	doxylamine succinate
MEDRT	D012221	Rhinitis, Allergic, Perennial	DISEASE	may_treat	doxylamine
MEDRT	D012223	Rhinitis, Vasomotor	DISEASE	may_treat	phenylephrine
MEDRT	D012223	Rhinitis, Vasomotor	DISEASE	may_treat	phenylephrine hydrochloride
MEDRT	D012772	Shock, Septic	DISEASE	may_treat	phenylephrine
MEDRT	D012772	Shock, Septic	DISEASE	may_treat	phenylephrine hydrochloride
MEDRT	D007319	Sleep Initiation and Maintenance Disorders	DISEASE	may_treat	doxylamine succinate
MEDRT	D007319	Sleep Initiation and Maintenance Disorders	DISEASE	may_treat	doxylamine
MEDRT	D013617	Tachycardia, Supraventricular	DISEASE	may_treat	phenylephrine
MEDRT	D013617	Tachycardia, Supraventricular	DISEASE	may_treat	phenylephrine hydrochloride
MEDRT	D017180	Tachycardia, Ventricular	DISEASE	ci_with	phenylephrine
MEDRT	D017180	Tachycardia, Ventricular	DISEASE	ci_with	phenylephrine hydrochloride
MEDRT	N0000000209	Adrenergic alpha-Agonists	MOA	has_moa	phenylephrine
MEDRT	N0000000209	Adrenergic alpha-Agonists	MOA	has_moa	phenylephrine hydrochloride
MEDRT	N0000000190	Histamine H1 Receptor Antagonists	MOA	has_moa	doxylamine succinate
MEDRT	N0000000190	Histamine H1 Receptor Antagonists	MOA	has_moa	doxylamine
MEDRT	N0000000108	Prostaglandin Receptor Antagonists	MOA	has_moa	acetaminophen
MEDRT	N0000175724	Central Nervous System Activity Alteration	PE	has_pe	acetaminophen
MEDRT	N0000008371	Conjunctival Arterial Vasoconstriction	PE	has_pe	phenylephrine hydrochloride
MEDRT	N0000008371	Conjunctival Arterial Vasoconstriction	PE	has_pe	phenylephrine
MEDRT	N0000008657	Decreased Histamine Activity	PE	has_pe	doxylamine
MEDRT	N0000008657	Decreased Histamine Activity	PE	has_pe	doxylamine succinate
MEDRT	N0000008896	Decreased Nasal and Sinus Secretions	PE	has_pe	phenylephrine hydrochloride
MEDRT	N0000008896	Decreased Nasal and Sinus Secretions	PE	has_pe	phenylephrine
MEDRT	N0000008836	Decreased Prostaglandin Production	PE	has_pe	acetaminophen
MEDRT	N0000009072	Hypothalamic Endocrine Activity Alteration	PE	has_pe	acetaminophen
MEDRT	N0000175725	Peripheral Nervous System Activity Alteration	PE	has_pe	acetaminophen
MEDRT	N0000000026	Hepatic Metabolism	PK	has_pk	acetaminophen
MEDRT	N0000000042	Renal Excretion	PK	has_pk	acetaminophen

Group, Type, Concept table
Group	Type	Concept	Source
DF	DF	Oral Capsule	rxnav_allrelated
DFG	DFG	Oral Product	rxnav_allrelated
DFG	DFG	Pill	rxnav_allrelated
GPCK	GPCK	{1 (acetaminophen 325 MG / doxylamine succinate 6.25 MG / phenylephrine hydrochloride 5 MG Oral Capsule) / 1 (acetaminophen 325 MG / phenylephrine hydrochloride 5 MG Oral Capsule) } Pack	rxnav_allrelated
IN	IN	acetaminophen	rxnav_allrelated
IN	IN	doxylamine	rxnav_allrelated
IN	IN	phenylephrine	rxnav_allrelated
MIN	MIN	acetaminophen / doxylamine / phenylephrine	rxnav_allrelated
PIN	PIN	doxylamine succinate	rxnav_allrelated
PIN	PIN	phenylephrine hydrochloride	rxnav_allrelated
SCD	SCD	acetaminophen 325 MG / doxylamine succinate 6.25 MG / phenylephrine hydrochloride 5 MG Oral Capsule	rxnav_allrelated
SCDC	SCDC	acetaminophen 325 MG	rxnav_allrelated
SCDC	SCDC	doxylamine succinate 6.25 MG	rxnav_allrelated
SCDC	SCDC	phenylephrine hydrochloride 5 MG	rxnav_allrelated
SCDF	SCDF	acetaminophen / doxylamine / phenylephrine Oral Capsule	rxnav_allrelated
SCDFP	SCDFP	acetaminophen / doxylamine succinate / phenylephrine hydrochloride Oral Capsule	rxnav_allrelated
SCDG	SCDG	acetaminophen / doxylamine / phenylephrine Oral Product	rxnav_allrelated
SCDG	SCDG	acetaminophen / doxylamine / phenylephrine Pill	rxnav_allrelated
SCDGP	SCDGP	acetaminophen / doxylamine succinate / phenylephrine hydrochloride Oral Product	rxnav_allrelated
SCDGP	SCDGP	acetaminophen / doxylamine succinate / phenylephrine hydrochloride Pill	rxnav_allrelated

Properties#

Category, Property, Value table
Category	Property	Value
ATTRIBUTES	AVAILABLE_STRENGTH	325 MG / 6.25 MG (expressed as doxylamine succinate) / 5 MG
ATTRIBUTES	GENERAL_CARDINALITY	MULTI
ATTRIBUTES	HUMAN_DRUG	US
ATTRIBUTES	PRESCRIBABLE	Y
ATTRIBUTES	RXNAV_HUMAN_DRUG	US
ATTRIBUTES	TTY	SCD
CODES	MMSL_CODE	BD28700
CODES	MMSL_CODE	CD28700
CODES	RxCUI	1052647
CODES	SPL_SET_ID	0f3b1404-9252-470a-aa8c-b360c85731f3
CODES	SPL_SET_ID	413d82d3-a896-4f15-9fca-c1b7b9a1ee63
CODES	SPL_SET_ID	d538445e-a47d-4983-844f-38aa303d11fd
NAMES	Prescribable Synonym	acetaminophen 325 MG / doxylamine succinate 6.25 MG / phenylephrine HCl 5 MG Oral Capsule
NAMES	RXNAV_STR	acetaminophen 325 MG / doxylamine succinate 6.25 MG / phenylephrine hydrochloride 5 MG Oral Capsule
NAMES	RxNorm Name	acetaminophen 325 MG / doxylamine succinate 6.25 MG / phenylephrine hydrochloride 5 MG Oral Capsule
NAMES	RxNorm Synonym	APAP 325 MG / doxylamine succinate 6.25 MG / Phenylephrine Hydrochloride 5 MG Oral Capsule
SOURCES	Source	Gold Standard Alchemy
SOURCES	Source	Metathesaurus FDA Structured Product Labels